PR PolyResearch

Join Free

AMEX

Direxion Daily S&P Biotech Bear 3X ETF (LABD)

♥ 415 Thanks from members

The Direxion Daily S&P Biotech Bear 3X ETF (LABD) exhibits heavily negative performance year-to-date, reflecting severe erosion amid volatile inverse exposure to the biotech sector, alongside strong leverage and derivative-associated risks.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other NYSE American (AMEX) Tickers

iShares Top 20 U.S. Stocks ETF (TOPT)

Tema U.S. Manufacturing & Reshoring ETF (WELD)

Gabelli Opportunities in Live and Sports ETF (GOLS)

MicroSectors FANG+ 3X Leveraged ETNs (FNGU)

iShares U.S. Pharmaceutical ETF (IHE)

iShares Core 80/20 Aggressive Allocation ETF (AOA)